Cyclosporine controls epidermolysis bullosa acquisita co‐occurring with acquired factor VIII deficiency

Abstract

Cyclosporine should be considered when EBA and/or acquired factor VIII deficiency fail to respond to conservative therapy. Both conditions usually respond rapidly to cyclosporine 4-6 mg/kg/day.